Evidence map›Paper›PMID 42478785›Full record

ArticleJournal of the American Chemical Society2026

2-Alkyl Furans Undergo Radiolytic Oxidative Protein Cross-Linking.

Oluwatosin R Ayinde, Minervo Perez, Kiall F Suazo, Ying Xiong, Thorkell Andresson, Jordan L Meier, Martin Schnermann

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Oluwatosin R AyindeChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland21702, United States.
Minervo PerezChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland21702, United States.ORCID 0000-0002-2768-4954
Kiall F SuazoProtein and Metabolite Characterization Core, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, Maryland21701, United States.
Ying XiongChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland21702, United States.ORCID 0009-0009-8835-202X
Thorkell AndressonProtein and Metabolite Characterization Core, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Frederick, Maryland21701, United States.
Jordan L MeierChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland21702, United States.ORCID 0000-0002-0537-7101
Martin SchnermannChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland21702, United States.ORCID 0000-0002-0503-0116

Funding

Targeting Cancer Through Modifications and MetabolismZIABC011488 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MEIER, JORDAN L · 2013 to 2025
$21.3M
Near-IR Photorelease Chemistry: Discovery and ApplicationsZIABC011564 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNERMANN, MARTIN · 2014 to 2025
$9.5M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC011488Intramural NIH HHS ZIA BC011564National Institutes of Health (NIH) BC011564NCI NIH HHS HHSN261200800001ENIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Induced covalent bond formation, or cross-linking, is a powerful strategy for interrogating and modulating biological systems. Current strategies rely largely on photochemical processes, which generally restrict their use to cellular or other optically accessible settings. Broadening the chemistry underlying the cross-linking-initiating event could extend these approaches to more complex biological systems. Ionizing radiation─a cornerstone of cancer therapy─is an attractive but unexplored trigger for covalent chemistry. Here, we detail the systematic comparison of a series of rationally designed radiolytic cross-linking candidates. These studies reveal that 2-alkyl furans efficiently label a representative protein in a radiation dose-dependent manner. Mechanistic analyses suggest that radiolysis induces hydroxyl radical-mediated oxidation of the furan, generating an electrophilic dicarbonyl intermediate that reacts with lysine residues to form stable adducts. We apply this strategy to enforce the covalent capture of an otherwise reversible small-molecule-protein interaction in cells. Together, these findings establish ionizing radiation as an effective trigger for covalent chemistry, expanding the scope of radiolytic chemistry to include bond formation. This work provides a foundation for future applications leveraging spatially targeted radiation for target identification or the development of next-generation therapeutic strategies.

Indexed as

Cross-Linking ReagentsFuransProteinsHumansMolecular StructureOxidation-ReductionCross-Linking ReagentsFuransProteins

Identifiers

PMID42478785
PMCPMC13637746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.